The third edition of Translational Research Methods for the Metabolic Continuum: A Focus on Early Phase Clinical Drug Development is now available for pre-order!

An invaluable resource for translational scientists, clinicians, and drug developers, Translational Research Methods provides practical insights into the evolving strategies shaping the future of early-phase drug development.

The book describes the growing importance of MASLD within the broader cardiometabolic disease landscape and highlights emerging approaches to biomarkers, functional imaging, computational modeling, and precision medicine.

The book features a chapter by Kinexum experts Alexander Fleming and Brian Harvey, entitled Regulatory Considerations for Early Study and Clinical Development of Drugs for Diabetes, Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and Other Disorders in the Metabolic Continuum.

Release is slated for September 13, 2026.You can pre-order it here.